| 1 (24) | DeepMind Technologies Ltd | GBR |  |
| 2 (82) | Alphabet Inc * | MUL | |
| 3 (97) | Google International LLC | MUL | |
| 4 (101) | Google Inc, USA | USA | |
| 5 (149) | Facebook Inc * | MUL | |
| 5 (149) | Facebook Inc, United States | USA | |
| 6 (155) | Microsoft Corp * | MUL | |
| 7 (160) | Microsoft, USA | USA | |
| 8 (189) | Microsoft Research, Asia | CHN | |
| 9 (233) | Novo Nordisk A/S | DNK | |
| 10 (234) | Novo Nordisk * | MUL | |
| 11 (278) | GlaxoSmithKline * | MUL | |
| 12 (279) | Microsoft Research, Cambridge | GBR | |
| 13 (280) | Regeneron Pharmaceuticals Inc | USA | |
| 14 (283) | Samsung Corp * | MUL | |
| 15 (284) | Novartis * | MUL | |
| 16 (285) | IBM Research * | MUL | |
| 16 (285) | F Hoffmann-La Roche * | MUL | |
| 17 (298) | Genentech Inc | USA | |
| 17 (298) | AstraZeneca * | MUL | |
| 18 (299) | Hoffmann-La Roche, Ltd., United States | USA | |
| 19 (303) | GlaxoSmithKline, Belgium | BEL | |
| 20 (308) | Gilead Sciences Inc, United States | USA | |
| 20 (308) | Gilead Sciences * | MUL | |
| 21 (310) | Pfizer * | MUL | |
| 22 (312) | GlaxoSmithKline, United States | USA | |
| 23 (317) | NVIDIA Corp | USA | |
| 23 (317) | Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique | FRA | |
| 24 (318) | GlaxoSmithKline, United Kingdom | GBR | |
| 25 (319) | Pfizer Inc, United States | USA | |
| 26 (320) | Janssen | MUL | |
| 27 (322) | Novartis, Switzerland | CHE | |
| 27 (322) | Johnson & Johnson * | MUL | |
| 28 (323) | Biogen Idec, USA | USA | |
| 29 (324) | Biogen Idec * | MUL | |
| 29 (324) | IBM United States | USA | |
| 30 (327) | Janssen Biotech Inc | USA | |
| 31 (328) | RTI Health Solutions | USA | |
| 31 (328) | Merck * | MUL | |
| 32 (329) | Sanofi * | MUL | |
| 33 (331) | Novartis Institutes for Biomedical Research, United States | USA | |
| 34 (334) | Merck & Co Inc, United States | USA | |
| 34 (334) | Sanofi, United States | USA | |
| 35 (338) | Celgene Corp | USA | |
| 36 (339) | AstraZeneca, United Kingdom | GBR | |
| 36 (339) | Eli Lilly * | MUL | |
| 37 (349) | MedImmune, LLC. | USA | |
| 37 (349) | Boehringer Ingelheim GmbH Germany | DEU | |
| 37 (349) | Boehringer Ingelheim * | MUL | |
| 38 (350) | AstraZeneca, United States | USA | |
| 39 (352) | Eli Lilly and Company, United States | USA | |
| 39 (352) | Hoffmann-La Roche, GmbH., Germany | DEU | |
| 40 (353) | Lockheed Martin Corp * | USA | |
| 40 (353) | Novartis Institutes for Biomedical Research, Switzerland | CHE | |
| 41 (354) | Bayer * | MUL | |
| 42 (355) | AstraZeneca, Sweden | SWE | |
| 43 (358) | Bayer AG, Germany | DEU | |
| 44 (359) | UCB Pharma S.A. * | MUL | |
| 45 (360) | IMEC International | BEL | |
| 46 (361) | UCB Pharma S.A., Brussels | BEL | |
| 47 (362) | Amgen * | MUL | |
| 48 (363) | Unilever, United Kingdom | GBR | |
| 49 (365) | Amgen, USA | USA | |
| 50 (367) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 51 (369) | Manipal Global Education Group * | MUL | |
| 51 (369) | Janssen Research & Development, LLC | BEL | |
| 52 (370) | Takeda Pharmaceuticals International Inc, USA | USA | |
| 52 (370) | Australian Synchrotron | AUS | |
| 53 (371) | Nokia Corp * | MUL | |
| 53 (371) | Nestle Switzerland | CHE | |
| 54 (372) | IBM Switzerland Research Laboratory | CHE | |
| 55 (373) | Nestle * | MUL | |
| 56 (374) | Allergan plc * | MUL | |
| 56 (374) | Allergan plc, USA | USA | |
| 56 (374) | Bristol-Myers Squibb Company * | MUL | |
| 57 (375) | Bristol-Myers Squibb Company, United States | USA | |
| 58 (379) | Monsanto | MUL | |
| 59 (380) | Novartis Pharmaceuticals, United States | USA | |
| 59 (380) | Siemens Healthineers, USA | USA | |
| 60 (381) | Alcatel-Lucent, United States | USA | |
| 60 (381) | Pfizer Inc, United Kingdom | GBR | |
| 61 (384) | SINTEF Group | NOR | |
| 61 (384) | Takeda Pharmaceuticals International, Inc * | MUL | |
| 62 (385) | Intel Corp, USA | USA | |
| 63 (386) | Alcatel-Lucent | MUL | |
| 64 (387) | Unilever * | MUL | |
| 65 (390) | Intel Corp * | MUL | |
| 66 (391) | Syngenta * | MUL | |
| 67 (393) | Estacio Participacoes SA * | BRA | |
| 67 (393) | Boehringer Ingelheim, USA | USA | |
| 68 (394) | Mitsubishi Electric Research Laboratories | USA | |
| 69 (396) | Mitsubishi Chemical Holdings Corp | MUL | |
| 70 (400) | VTT Technical Research Centre of Finland | FIN | |
| 70 (400) | Science System and Applications, Inc | USA | |
| 71 (401) | Shionogi & Co Ltd | JPN | |
| 71 (401) | DuPont | USA | |
| 72 (402) | BMJ Group | GBR | |
| 73 (404) | Koninklijke Philips NV * | MUL | |
| 74 (406) | Abt Associates Inc | USA | |
| 74 (406) | Daiichi Sankyo Co., Ltd. * | MUL | |
| 74 (406) | GE Healthcare | MUL | |
| 75 (408) | GNS Science | NZL | |
| 75 (408) | State Grid Corporation of China * | CHN | |
| 75 (408) | Sincrotrone Trieste | ITA | |
| 76 (411) | European XFEL GmbH | DEU | |
| 77 (412) | Johnson & Johnson, United States | USA | |
| 77 (412) | Daiichi Sankyo Co., Ltd. Japan | JPN | |
| 78 (413) | Siemens * | MUL | |
| 78 (413) | Rolls-Royce plc, United Kingdom | GBR | |
| 78 (413) | Procter & Gamble, USA | USA | |
| 78 (413) | Procter & Gamble Co * | MUL | |
| 79 (414) | Toyota Group * | MUL | |
| 79 (414) | General Atomics | USA | |
| 79 (414) | Merck KGaA, Germany | DEU | |
| 80 (415) | Tencent | CHN | |
| 81 (416) | Bayer Corp, USA | USA | |
| 81 (416) | China National Petroleum Corp * | CHN | |
| 81 (416) | Ericsson * | MUL | |
| 82 (417) | Nokia Networks, Germany | DEU | |
| 82 (417) | Astellas Pharma Inc | JPN | |
| 82 (417) | Philips Research, Eindhoven | NLD | |
| 82 (417) | Shell, Netherlands | NLD | |
| 83 (418) | BASF, Germany | DEU | |
| 84 (419) | Medtronic Inc, USA | USA | |
| 84 (419) | Hewlett Packard * | MUL | |
| 84 (419) | GE Healthcare Bio-Sciences | USA | |
| 85 (420) | Samsung Electronics, South Korea | KOR | |
| 85 (420) | Ericsson Sweden | SWE | |
| 85 (420) | Plant and Food Research | NZL | |
| 86 (421) | Robert Bosch * | MUL | |
| 86 (421) | General Electric Company * | MUL | |
| 86 (421) | Takeda Pharmaceutical Co Inc, Japan | JPN | |
| 86 (421) | Medtronic * | MUL | |
| 86 (421) | ARUP Laboratories | USA | |
| 87 (423) | Nippon Telegraph and Telephone Corp | JPN | |
| 88 (425) | HP Inc, USA | USA | |
| 89 (426) | Abbott Laboratories * | MUL | |
| 89 (426) | Qualcomm Inc, USA | USA | |
| 89 (426) | Qualcomm Inc * | MUL | |
| 90 (427) | NEC Corp * | MUL | |
| 90 (427) | BASF Group * | MUL | |
| 91 (428) | Siemens AG, Germany | DEU | |
| 91 (428) | Jaguar Land Rover Ltd. | GBR | |
| 91 (428) | Sony Corp * | MUL | |
| 92 (429) | Huawei Technologies Co Ltd * | MUL | |
| 92 (429) | Huawei Software Technology Co Ltd, China | CHN | |
| 93 (430) | Schlumberger * | MUL | |
| 93 (430) | Mitsubishi Corp * | MUL | |
| 94 (431) | Taiwan Semiconductor Manufacturing Company Ltd. | TWN | |
| 94 (431) | Shell * | MUL | |
| 94 (431) | Thales Group France, S.A. | FRA | |
| 95 (432) | Siemens AG, USA | USA | |
| 95 (432) | Daimler AG | DEU | |
| 96 (433) | Cisco Systems | USA | |
| 96 (433) | Toyota Central R&D Labs Inc, Japan | JPN | |
| 96 (433) | Panasonic Corp, Japan | JPN | |
| 96 (433) | Electricite de France, S.A. * | FRA | |
| 97 (434) | Rolls-Royce Holdings plc * | MUL | |
| 97 (434) | Panasonic Corp * | MUL | |
| 97 (434) | DowDupont * | MUL | |
| 97 (434) | PetroChina Co Ltd | CHN | |
| 97 (434) | ExxonMobil * | MUL | |
| 97 (434) | ExxonMobil, USA | USA | |
| 98 (435) | Schlumberger, United States | USA | |
| 99 (436) | AT&T Mobility * | MUL | |
| 100 (437) | Atomic Weapons Establishment | GBR | |
| 100 (437) | Sony Japan | JPN | |
| 101 (440) | Aramco Services Co, United States | USA | |
| 101 (440) | Cisco Systems Inc * | MUL | |
| 102 (441) | Nokia Bell Labs, France | FRA | |
| 102 (441) | Agilent Technologies * | MUL | |
| 103 (442) | IBM Ireland Research | IRL | |
| 104 (443) | Nokia, Finland | FIN | |
| 104 (443) | Nokia Networks, France | FRA | |
| 105 (444) | Thales Group * | MUL | |
| 106 (447) | France Telecom * | MUL | |
| 106 (447) | France Telecom, S.A. | FRA | |
| 107 (448) | BMW AG, Germany | DEU | |
| 107 (448) | BMW Group * | MUL | |
| 108 (449) | General Electric Co, USA | USA | |
| 109 (451) | Mitsubishi Electric Corp | MUL | |
| 110 (452) | The Kansai Electric Power Company | JPN | |
| 111 (453) | Toshiba Corp * | MUL | |
| 111 (453) | Airbus SAS * | MUL | |
| 111 (453) | Sumitomo Group * | MUL | |
| 111 (453) | Springer Nature * | MUL | |
| 111 (453) | Chevron Corp | USA | |
| 111 (453) | BP plc * | MUL | |
| 111 (453) | ABB Corporate Research Center, Sweden | SWE | |
| 112 (455) | Boeing Co, USA | USA | |
| 112 (455) | Bosch, Germany | DEU | |
| 113 (456) | ABB Group * | MUL | |
| 113 (456) | Boeing Co * | MUL | |
| 113 (456) | United Technologies Corp, USA | USA | |
| 114 (457) | General Motors Company, United States | USA | |
| 114 (457) | Toyota Motor Corp, Japan | JPN | |
| 114 (457) | Shell, USA | USA | |
| 115 (458) | United Technologies Corp * | MUL | |
| 115 (458) | STMicroelectronics * | MUL | |
| 116 (459) | Springer Nature, New Zealand | NZL | |
| 116 (459) | Equinor ASA * | MUL | |
| 117 (460) | Corning, USA | USA | |
| 118 (461) | Infineon Technologies Germany | DEU | |
| 118 (461) | Corning * | MUL | |
| 118 (461) | Northrop Grumman Corp, USA | USA | |
| 119 (462) | Airbus, Germany | DEU | |
| 120 (463) | ABB AB, Sweden | SWE | |
| 121 (464) | Equinor ASA, Norway | NOR | |
| 121 (464) | Raytheon Co, USA | USA | |
| 121 (464) | Tata Group * | MUL | |
| 122 (466) | Renault SAS * | MUL | |
| 122 (466) | Renault SAS, France | FRA | |
| 122 (466) | IBM India Research Laboratory | IND | |
| 122 (466) | Total, France | FRA | |
| 123 (467) | Hamamatsu Photonics KK, Japan | JPN | |
| 123 (467) | Hamamatsu Photonics * | MUL | |
| 123 (467) | Hitachi * | MUL | |
| 123 (467) | Raytheon Co * | MUL | |
| 123 (467) | STMicroelectronics, France | FRA | |
| 123 (467) | Nippon Steel Corp, Japan | JPN | |
| 123 (467) | Nippon Steel Corp * | MUL | |
| 124 (468) | LG Electronics, South Korea | KOR | |
| 124 (468) | Aramco * | MUL | |
| 125 (469) | General Motors Company * | MUL | |
| 125 (469) | Toshiba Corp Japan | JPN | |
| 126 (470) | LG Corporation * | MUL | |
| 126 (470) | Denso Corp, Japan | JPN | |
| 127 (471) | TOTAL * | MUL | |
| 127 (471) | ABB, Switzerland | CHE | |
| 128 (472) | Rolls-Royce Singapore Pte Ltd | SGP | |
| 129 (474) | STMicroelectronics, Italy | ITA | |
| 130 (475) | Sumitomo Electric Ind Ltd, Japan | JPN | |
| 131 (476) | Volkswagen AG, Germany | DEU | |
| 131 (476) | Denso Corp | MUL | |
| 131 (476) | Infineon Technologies * | MUL | |
| 131 (476) | Sumitomo Electric Ind Ltd | MUL | |
| 131 (476) | Dow Chemical Co | MUL | |
| 132 (477) | China Petroleum and Chemical Corporation * | CHN | |
| 133 (478) | JFE Holdings Inc * | MUL | |
| 133 (478) | MITRE Corp, Bedford * | USA | |
| 133 (478) | China Electric Power Research Institute | CHN | |
| 133 (478) | Volkswagen AG * | MUL | |
| 133 (478) | Saudi Arabian Oil Company | SAU | |
| 133 (478) | Hitachi Ltd, Japan | JPN | |
| 133 (478) | JFE Holdings Inc, Japan | JPN | |
| 134 (479) | Wuhan Textile University | CHN | |
| 134 (479) | NEC Japan | JPN | |
| 134 (479) | Dow Chemical Co USA | USA | |
| 135 (480) | Texas Instruments, US | USA | |
| 135 (480) | Airbus, France | FRA | |
| 135 (480) | Tata Consultancy Services Ltd | IND | |
| 135 (480) | Infineon Technologies Austria AG | AUT | |
| 135 (480) | ConocoPhillips Co, USA | USA | |
| 135 (480) | ConocoPhillips Co * | MUL | |
| 136 (481) | Schlumberger, United Kingdom | GBR | |
| 137 (482) | ARUP | GBR | |
| 137 (482) | State Grid Energy Research Institute | CHN | |
| 137 (482) | Fujitsu * | MUL | |
| 137 (482) | ABB Corporate Research Center, United States | USA | |
| 138 (485) | Texas Instruments * | MUL | |
| 139 (486) | MITRE Corp, McLean | USA | |
| 139 (486) | Ford Motor Company * | MUL | |
| 140 (487) | Ford Motor Co, USA | USA | |
| 140 (487) | ABB, United States | USA | |
| 141 (488) | ZTE, China | CHN | |
| 141 (488) | ZTE Corp * | MUL | |
| 141 (488) | Tata Sons Ltd | IND | |
| 142 (490) | China State Institute of Pharmaceutical Industry | CHN | |
| 142 (490) | Fujitsu, Japan | JPN | |
| 142 (490) | Fuji Electric * | MUL | |
| 142 (490) | Fuji Electric, Japan | JPN | |
| 143 (491) | Baker Hughes | MUL | |
| 143 (491) | Tata Steel Ltd | IND | |
| 144 (492) | NXP Semiconductors NV * | MUL | |
| 144 (492) | Petrobras * | MUL | |
| 145 (493) | Mitsubishi Electric Corp, Japan | JPN | |
| 145 (493) | Petrobras Brasil | BRA | |
| 146 (496) | China Coal Research Institute | CHN | |
| 147 (497) | Aerospace Corp | USA | |
| 147 (497) | Baker Hughes, USA | USA | |
| 148 (498) | Mitsubishi Heavy Industries, Japan | JPN | |
| 149 (499) | IHI Corp, Japan | JPN | |
| 149 (499) | IHI Corp * | MUL | |
| 149 (499) | Honda Motor Co Ltd * | MUL | |
| 149 (499) | Honda Motor Co Ltd, Japan | JPN | |
| 149 (499) | State Grid Zhejiang Electric Power Co | CHN | |
| 150 (500) | Mitsubishi Heavy Industries Ltd | MUL | |
| 151 (501) | AECOM | USA | |
| 151 (501) | Beijing Institute of Aeronautical Materials | CHN | |
| 152 (508) | Korea Electric Power Corp * | KOR | |
| 153 (509) | State Grid Shandong Electric Power Research Institute | CHN | |
| 154 (510) | Synopsys Inc * | MUL | |
| 155 (513) | General Research Institute for Nonferrous Metals * | CHN | |
| 155 (513) | State Grid Tianjin Electric Power Co | CHN | |
| 156 (514) | Aselsan | TUR | |
| 156 (514) | State Grid Electric Power Research Institute, Nanjing | CHN | |
| 157 (516) | State Grid Shandong Electric Power Co | CHN | |
| 157 (516) | China National Offshore Oil Corp * | CHN | |
| 158 (517) | China Electronics Technology Group Corp | CHN | |
| 158 (517) | State Grid Hunan Electric Power Corp | CHN | |
| 158 (517) | Jiangsu Electric Power Company | CHN | |
| 159 (518) | Synopsys, USA | USA | |
| 160 (520) | Shanghai Municipal Electric Power Company | CHN | |
| 160 (520) | State Grid Hubei Electric Power Co | CHN | |
| 161 (524) | Hyundai Motor Co, South Korea | KOR | |
| 162 (525) | Hyundai Motor Group * | MUL | |
| 163 (533) | State Grid Beijing Electric Power Co | CHN | |
| 164 (536) | RELX Group plc * | MUL | |
| 165 (538) | China Railway Eryuan Engineering Group Co Ltd | CHN | |
| 165 (538) | China Railway Group Ltd | CHN | |
| 165 (538) | China Railway Engineering Corp * | CHN | |
| 166 (540) | Elsevier, France | FRA | |
|
